newsfilter
← Latest News
GlobeNewswire·

Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee

  • Nano Dimension Ltd. appointed Nadav Kidron to its Board of Directors on August 17, 2026.
  • The Board plans to establish a Strategy and Capital Allocation Committee to evaluate capital allocation alternatives & maximize long-term shareholder value.
  • Mr. Kidron will chair the new committee while working with Chairman Phillip Borenstein & management.
  • Mr. Kidron currently serves as President & CEO of Oramed Pharmaceuticals Inc., a significant Nano Dimension shareholder.
  • His background includes leading Oramed's strategic repositioning, which grew its balance sheet from approximately $160 million to over $370 million.
  • He also sits on the boards of Alpha Tau Medical Ltd. & Lifeward Ltd.
  • Chairman Phillip Borenstein stated the Board aims to simplify the company, strengthen its financial position, & establish a disciplined framework for the next phase.
  • Mr. Kidron highlighted Nano's strong balance sheet & significant strategic flexibility as key assets for his contribution.
  • The press release includes forward-looking statements regarding future growth, potential sale of MarkForged, Inc., & strategic alternatives to reduce complexity & cash burn.
  • Nano Dimension provides digital manufacturing technologies to customers in defense, aerospace, automotive, electronics, & medical device industries.